Cure Pharmaceutical Holding Corp. (IFIN)
NYSE
3.51
-0.34 (-8.83%)
Real-time Data
01:30 PM
Day's Range
3.453.95
52 wk Range
1.314.72
Financial Statements - IFIN - Cure Pharmaceutical Holding Corp.
Revenue
0
Net Income
3.14M
EBITDA
-2.02M
Free Cash Flow
-552.95K
Income Statement
| Period Ending | 2023-12-31 |
|---|---|
| Sales | 0 |
| Cost of Goods | - |
| Gross Profit | - |
 Operating Expense | - |
| Operating Income | -2.02M |
| Non-Operating Interest | - |
| Other Income Expense | - |
| Pre Tax Income | 3.14M |
| Income Tax | - |
| Net Income | 3.14M |
| EPS Basic | 0.2 |
| EPS Diluted | 0.2 |
| Basic Shares Outstanding | 5.83M |
| Diluted Shares Outstanding | 5.83M |
| Ebit | -2.02M |
| Ebitda | -2.02M |
| Net Income Continuous Operations | 3.14M |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
